Status:
COMPLETED
The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Pain
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Adding sufentanyl to bupivacain in Transversus Abdominis Plane (TAP) block under ultrasound guide can reduce narcotic dosage, side effects and pain after cesarean delivery.
Eligibility Criteria
Inclusion
- female 18 to 40 Years
- class ASA 1 and 2
- candidates for elective cesarean section
Exclusion
- renal failure
- liver failure
- cardiac disorder
- coagulopathy
- hepatomegaly
- splenomegaly
- drug sensitivity and abuse
- morbid obesity
- smoking
- history of post operative nausea and vomiting
- motion sickness
- local hypoesthesia
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01516268
Start Date
January 1 2012
End Date
February 1 2013
Last Update
March 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shariati hospital, TUMS
Tehran, Iran, 14114